Beranda › Gumpalan Darah › Indiana
Uji klinis Gumpalan Darah di Indiana
7 studi untuk Gumpalan Darah mencari peserta di lokasi di Indiana.
Kota di Indiana
Teks studi resmi (Bahasa Inggris)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Profound Research, Powers Health Medical Group - Electrophysiology, Munster
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Indiana University, Indianapolis
- Blue Coast Research Center, LLC, Indianapolis
- Franciscan Physician Network, Indiana Heart Physicians, Indianapolis
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07175428Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Profound Research, Powers Health Medical Group, Munster
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07318610Aspiration Thrombectomy Using the Symphony or Prodigy System
- Profound Research, Munster
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07350499Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Indiana Medical Research, Merrillville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07430956ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Indiana Hemophilia and Thrombosis Center, Indianapolis
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628Rapid Evacuation and Access of Cerebral Hemorrhage Trial
- St Vincent Hospital/Goodman Campbell Brain and Spine, Indianapolis
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06870812Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.